Showing results (381-390 of 1,769) with videos related to
Sort By:
Pageof 177
Gynecologic Oncology Reports|February 16, 2024
Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literatureAnnalyn M Welp, Linda R DuskaGynecologic Oncology Reports|February 29, 2024
Association between alteration of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, cancer antigen-125 and surgical outcomes in advanced stage ovarian cancer patient who received neoadjuvant chemotherapyPonganun Tuntinarawat, Ratnapat Tangmanomana, Thannaporn KittisiamGynecologic Oncology Reports|March 1, 2024
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancerPanagiotis A Konstantinopoulos, Niya Xiong, Carolyn Krasner, et al.Gynecologic Oncology Reports|April 10, 2024
Management of ruptured ovarian teratoma mimicking advanced ovarian cancerKatherine Jane Chua, Alice Barr, Miranda Prints, et al.Gynecologic Oncology Reports|April 8, 2024
Cholecystectomy at the time of open cytoreductive surgery for ovarian cancerLindsey Finch, Danyal Ahsan Muhammad, Dennis S ChiGynecologic Oncology Reports|April 8, 2024
Germline MLH1 and MSH6 mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case reportYi-Ching Huang, Peng-Chan Lin, Pei-Ying Wu, et al.Gynecologic Oncology Reports|February 21, 2024
Cervical cancer management in a low resource setting: A 10-year review in a tertiary care hospital in KenyaAfrin F Shaffi, Elly B Odongo, Peter M Itsura, et al.Gynecologic Oncology Reports|February 26, 2024
Intranodal lymphangiography under microsurgery for refractory lymphatic ascites after pelvic lymphadenectomyShota Higami, Yusuke Tanaka, Daisuke Maeda, et al.Gynecologic Oncology Reports|February 5, 2024
A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapyRebecca Lin, Asyraf Muaadz, Ho Gwo FuangGynecologic Oncology Reports|May 23, 2024
Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancerShashank Sama, Sterling Rosqvist, Talicia Savage, et al.Pageof 177